FINWIRES · TerminalLIVE
FINWIRES

Recce Pharmaceuticals Enters Proposed 10-Year Exclusive Licensing Nonbinding Agreement with Middle Eastern Firm, Shares Rise 10%

By

Recce Pharmaceuticals (ASX:RCE) entered into a non-binding term sheet with a Middle Eastern pharmaceutical company for a proposed 10-year exclusive licensing arrangement covering the commercial sales and distribution of Recce's proprietary R327 topical gel for the treatment of diabetic foot infections, according to a Wednesday Australian bourse filing.

The agreement covers Saudi Arabia, the United Arab Emirates, Kuwait, Oman, Bahrain, Qatar, Iraq, Egypt, Algeria, and Morocco. Recce will be responsible for the manufacture and supply of the R327 topical gel.

The agreement is expected to include an upfront signing fee, together with milestone payments totalling up to $3.5 million. Recce is also expected to receive 30% of the net selling price, with an additional 6% annual royalty on net sales of over $50 million per year. The proposed selling price is $1,500 per treatment, subject to agreement with the regulatory authority in Saudi Arabia.

The parties are collaborating to finalize and execute a definitive agreement.

Its shares rose 10% in recent trading on Wednesday.

Related Articles

Asia

China Ruifeng Renewable Unit Acquires Land for AI Computing Center; Shares Jump 9%

China Ruifeng Renewable Energy (HKG:0527) said its wholly owned subsidiary Zhangjiakou Xingtu Intelligent Computing Technology acquired land use rights for four industrial land parcels in Zhangjiakou, Hebei province, for 84.9 million yuan, according to a Tuesday Hong Kong bourse filing.Shares of the firm rose nearly 9% in recent trade.The land, covering about 144,840 square meters, will be used for the first phase of the company's Xuanhua artificial intelligence computing power center project.

$HKG:0527
Asia

Mayank Cattle Food Launches New Multivitamin Product for Dairy Animals; Shares Up 4%

Mayank Cattle Food (BOM:544106) has launched a new cattle feed product named "Mayank Vita H Liquid" in the Indian market, according to a Wednesday filing to the BSE.Mayank Vita H Liquid is a combination of multivitamins and minerals specially formulated for livestock health and productivity. It helps to address nutritional deficiencies, supports metabolic functions, and enhances overall performance in dairy animals.The company expects the new product to boost revenue, diversify income sources, and enhance market penetration.The company's shares were up over 4% in recent trade.

$BOM:544106
Asia

Weiye Flags High Concentration of Shareholding

Weiye Holdings (HKG:1570) flagged a high concentration of shareholding in the firm's shares following a request from the Hong Kong Stock Exchange, according to a filing with the city's bourse Tuesday.The residential and commercial property developer's shares fell nearly 2% in late morning trade Wednesday.According to the notice, 20 shareholders collectively controlled 83.50% of the company's issued share capital, while another 13.12% of shares were registered under HKSCC Nominees' name, leaving only 3.38% of the issued shares in the hands of other shareholders.This meant that the shares may not have a genuine market and prices could fluctuate "substantially" even with a small number of shares traded, the firm said.

$HKG:1570